Post-IPO Equity - Oxford BioMedica
Investment Firm
Overview
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Announced Date
Sep 22, 2021
Funding Type
Post Ipo Equity
Highlights
Location
Europe
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
 Serum Institute of India Pvt. Ltd. |
Round Details and Background
Oxford BioMedica raised $68081491 on 2021-09-22 in Post-IPO Equity
Oxford BioMedica is a pioneer of gene and cell therapy, with a leading industry position in lentiviral vector and cell therapy research.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 23, 2018 |  Grant - Oxford BioMedica | 1 | - | 4.2M |
| Sep 11, 2013 | Post-IPO Equity - Oxford BioMedica | - | 11.2M | |
| Sep 22, 2021 | Post-IPO Equity - Oxford BioMedica | 1 | - | 68.1M |
| May 01, 2019 | Post-IPO Equity - Oxford BioMedica | 1 | - | 69.8M |
Recent Activity
There is no recent news or activity for this profile.